Personnel
Jerry McMahon named chairman of cancer therapeutics company
Published in Drug Week, July 23rd, 2004
McMahon was named NeoRx's CEO in May 2004 and will continue to serve in that position. He succeeds Jack L. Bowman, who retired as chairman and CEO last month.
McMahon's appointment to the board increases the number of directors from six to seven.
NeoRx opened enrollment in a phase III clinical trial of skeletal targeted radiotherapy in patients with multiple myeloma in March 2004. In April 2004, NeoRx acquired the rights to develop, manufacture, and commercialize Nexplatin, a...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
Source: Drug Week (2004-07-23)
More Articles from Drug Week
- Cancer Therapy
Encouraging results from NCI-sponsored study with FK228 in T-cell lymphomas - Drug Resistance
Cell cycle promotion sensitizes lung cancer cells to paclitaxel - Immunology
PrP-GFP expression models analyze activity of Prnp gene during prion infections - Mesothelioma
CHMP positive opinion granted for two cancer indications - Thrombosis
Heparin does not affect graft thrombosis incidence in pediatric renal allografts - Urinary Tract Infection
Extended-release ciprofloxacin effectively treats UTI and combats resistance - More from this issue of Drug Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
